Prevalence of Anemia in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Biomedical and environmental sciences : BES Pub Date : 2024-01-20 DOI:10.3967/bes2024.008

Monireh Faghir-Ganji, Narjes Abdolmohammadi, Maryam Nikbina, Alireza Amanollahi, Alireza Ansari-Moghaddam, Rozhan Rozhan, Hamidreza Baradaran

{"title":"Prevalence of Anemia in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis.","authors":"Monireh Faghir-Ganji, Narjes Abdolmohammadi, Maryam Nikbina, Alireza Amanollahi, Alireza Ansari-Moghaddam, Rozhan Rozhan, Hamidreza Baradaran","doi":"10.3967/bes2024.008","DOIUrl":null,"url":null,"abstract":"Objective: Anemia is a common public health concern in patients with type 2 diabetes worldwide. This study aimed to identify the prevalence of anemia among patients with diabetes.Methods: Electronic databases, including PubMed, Scopus, Web of Sciences, and Google Scholar, were searched systematically for studies published between 2010 and 2021. After removing duplicates and inappropriate reports, the remaining manuscripts were reviewed and appraised using theNewcastle-Ottawa Scale (NOS) tool. A random-effects model was used to calculate the pooled estimates of the extracted data using Stata version 17. Heterogeneity of the studies was assessed using the Q statistic.Results: A total of 51 articles containing information on 26,485 patients with diabetes were included in this study. The articles were mainly from Asia (58.82%) and Africa (35.29%). The overall prevalence of anemia was 35.45% (95% CI: 30.30-40.76), with no evidence of heterogeneity by sex. Among the two continents with the highest number of studies, the prevalence of anemia in patients with diabetes was significantly higher in Asia [40.02; 95% CI: 32.72-47.54] compared to Africa [28.46; 95% CI: 21.90-35.50] ( P for heterogeneity = 0.029). Moreover, there has been an increasing trend in the prevalence of anemia in patients with diabetes over time, from [15.28; 95% CI: 9.83-22.21] in 2012 to [40.70; 95% CI: 10.21-75.93] in 2022.Conclusion: Globally, approximately 4 in 10 patients with diabetes suffer from anemia. Therefore, routine anemia screening and control programs every 3 months might be useful in improving the quality of life of these patients.","PeriodicalId":93903,"journal":{"name":"Biomedical and environmental sciences : BES","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical and environmental sciences : BES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3967/bes2024.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Anemia is a common public health concern in patients with type 2 diabetes worldwide. This study aimed to identify the prevalence of anemia among patients with diabetes.

Methods: Electronic databases, including PubMed, Scopus, Web of Sciences, and Google Scholar, were searched systematically for studies published between 2010 and 2021. After removing duplicates and inappropriate reports, the remaining manuscripts were reviewed and appraised using theNewcastle-Ottawa Scale (NOS) tool. A random-effects model was used to calculate the pooled estimates of the extracted data using Stata version 17. Heterogeneity of the studies was assessed using the Q statistic.

Results: A total of 51 articles containing information on 26,485 patients with diabetes were included in this study. The articles were mainly from Asia (58.82%) and Africa (35.29%). The overall prevalence of anemia was 35.45% (95% CI: 30.30-40.76), with no evidence of heterogeneity by sex. Among the two continents with the highest number of studies, the prevalence of anemia in patients with diabetes was significantly higher in Asia [40.02; 95% CI: 32.72-47.54] compared to Africa [28.46; 95% CI: 21.90-35.50] ( P for heterogeneity = 0.029). Moreover, there has been an increasing trend in the prevalence of anemia in patients with diabetes over time, from [15.28; 95% CI: 9.83-22.21] in 2012 to [40.70; 95% CI: 10.21-75.93] in 2022.

Conclusion: Globally, approximately 4 in 10 patients with diabetes suffer from anemia. Therefore, routine anemia screening and control programs every 3 months might be useful in improving the quality of life of these patients.

查看原文本刊更多论文

糖尿病患者的贫血患病率：系统回顾与元分析》。

目的：贫血是全球 2 型糖尿病患者常见的公共卫生问题。本研究旨在确定糖尿病患者的贫血患病率：系统搜索了 2010 年至 2021 年间发表的研究报告，包括 PubMed、Scopus、Web of Sciences 和 Google Scholar 等电子数据库。在删除重复和不恰当的报告后，使用纽卡斯尔-渥太华量表（NOS）工具对剩余的手稿进行审查和评估。使用Stata 17版随机效应模型计算提取数据的汇总估计值。研究的异质性采用 Q 统计量进行评估：本研究共纳入 51 篇文章，包含 26 485 名糖尿病患者的信息。这些文章主要来自亚洲（58.82%）和非洲（35.29%）。贫血的总患病率为 35.45%（95% CI：30.30-40.76），无证据表明存在性别异质性。在研究数量最多的两大洲中，亚洲糖尿病患者的贫血患病率[40.02；95% CI：32.72-47.54]明显高于非洲[28.46；95% CI：21.90-35.50]（异质性 P = 0.029）。此外，随着时间的推移，糖尿病患者的贫血患病率呈上升趋势，从2012年的[15.28；95% CI：9.83-22.21]上升到2022年的[40.70；95% CI：10.21-75.93]：全球每 10 名糖尿病患者中约有 4 人患有贫血。因此，每 3 个月进行一次常规贫血筛查和控制计划可能有助于提高这些患者的生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biomedical and environmental sciences : BES

自引率

0.00%

发文量